ARCHIVES

FDA Advisors Ok Marketing Of Taxotere As Treatment For Advanced Breast Cancer

This article is from The Cancer Letter archive.

Vol. 21 No. 40 | October 20, 1995

Download PDF Visit The Full Archive

Related Articles

Funding Opportunity: EPA, NIEHS Set Aside $10M For Research On Disease Prevention In Children

September 19, 1997

NCCN Also to Warn Doctors. Amgen’s Pledges to Disclose Future Results.

February 23, 2007

Moses To Lead AACI.

October 19, 2001

FDA Approves Generic Oncology Injectable Currently In Shortage

September 27, 2013

NCI Getting a Lot For a Little Money It Spends Overseas, International Program Director Says

June 17, 1977

In Brief: CTEP Files IND For Antineoplaston, Mayo, MSK, Plan Trials; Researcher Escapes Bosnia

August 6, 1993